These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 7620338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tyrosinase activity in serum from patients with malignant melanoma.
    Agrup P, Carstam R, Wittbjer A, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1989; 69(2):120-4. PubMed ID: 2564228
    [Abstract] [Full Text] [Related]

  • 3. Seasonal variation of tyrosinase activity in serum.
    Sonesson B, Eide S, Rorsman H, Rosengren E.
    Acta Derm Venereol; 1995 Jul; 75(4):283-6. PubMed ID: 8578949
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serum tyrosinase in malignant disease, its activity, and the electrophoretic patterns of the enzyme as carried by immunoglobulins'.
    Chen YM, Lim BT, Chavin W.
    Cancer Res; 1979 Sep; 39(9):3485-90. PubMed ID: 113092
    [Abstract] [Full Text] [Related]

  • 6. Detection of tyrosinase mRNA from the blood of melanoma patients.
    Stevens GL, Scheer WD, Levine EA.
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of melanoma metastases by tyrosinase-reverse transcription-polymerase chain reaction of fine needle aspirates.
    Voit C, Schoengen A, Weber L, Proebstle T.
    J Am Acad Dermatol; 1998 Dec; 39(6):1030-2. PubMed ID: 9843026
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An animal model for the survival of tyrosinase isozymes in serum.
    Vachtenheim J, Duchon J, Matous B.
    Arch Dermatol Res; 1984 Dec; 276(2):111-4. PubMed ID: 6426408
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes.
    Bieligk SC, Ghossein R, Bhattacharya S, Coit DG.
    Ann Surg Oncol; 1999 Dec; 6(3):232-40. PubMed ID: 10340881
    [Abstract] [Full Text] [Related]

  • 16. The detection of tyrosinase mRNA in peripheral blood samples is unlikely to aid in the management of patients with localised malignant melanoma.
    Warr RP, Zebedee Z, Kenealy J, Rigby H, Kemshead JT.
    Br J Plast Surg; 2003 Sep; 56(6):540-5. PubMed ID: 12946371
    [Abstract] [Full Text] [Related]

  • 17. Characterization of structural properties for morphological differentiation of melanosomes: I. Purification of tyrosinase by tyrosine affinity chromatography and its characterization in B16 and Harding Passey melanomas.
    Jimbow K, Jimbow M, Chiba M.
    J Invest Dermatol; 1981 Aug; 77(2):213-8. PubMed ID: 6792293
    [Abstract] [Full Text] [Related]

  • 18. [Heterogeneity of tyrosinases isolated from rat skin, normal human skin, and human melanoma tumors].
    Sukhanov VA, D'iakov VL, Lalaev VV, Iakh''iaev AV.
    Biokhimiia; 1991 Jun; 56(6):1026-35. PubMed ID: 1932336
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.